- Level
- 17,168-0.38%
- 1M return
- +9.5%
- 3M return
- +4.5%
- 1Y return
- +15.4%
- From 52W high
- -2.4%
- P/E
- 46.4
- P/B
- 5.67
- Div yield
- 0.49%
17,168-0.38%16 Nov 2026
Returns
- 1M
- +9.5%
- 3M
- +4.5%
- 1Y
- +15.4%
- 52W high
- -2.4%
Valuation
- P/E
- 46.4
- P/B
- 5.67
- Div yield
- 0.49%
Nifty Healthcare P/E ratio and valuation
Nifty Healthcare constituents
15 of 20 above their 200-day average·9 rose, 11 fell on 16 Nov 2026
| # | Company | Sector | LTP | 1D | 1M | 3M | 1Y | 52WH % | P/E | M.CapM.Cap (₹ Cr) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries LimitedSUNPHARMA | Healthcare | 1,868 | -0.7% | +6.2% | -0.8% | +6.3% | -8.8% | 40.9 | 4,48,076 |
| 2 | Divi's Laboratories LimitedDIVISLAB | Healthcare | 11,080 | -3.2% | +21.2% | +30.6% | +70.2% | -6.3% | 87.5 | 2,94,139 |
| 3 | Torrent Pharmaceuticals LimitedTORNTPHARM | Healthcare | 4,691 | +0.5% | +2.9% | -4.3% | +22.4% | -10.6% | 84.0 | 1,78,438 |
| 4 | Apollo Hospitals Enterprise LimitedAPOLLOHOSP | Healthcare | 8,771 | +2.9% | +11.2% | -0.6% | +18.2% | -3.3% | 56.3 | 1,26,114 |
| 5 | Laurus Labs LimitedLAURUSLABS | Healthcare | 2,220 | -8.4% | +7.8% | +22.7% | +122.2% | -10.8% | 89.5 | 1,19,949 |
| 6 | Zydus Lifesciences LimitedZYDUSLIFE | Healthcare | 1,192 | +0.2% | +6.1% | +5.4% | +26.2% | -5.9% | 28.4 | 1,18,902 |
| 7 | Dr. Reddy's Laboratories LimitedDRREDDY | Healthcare | 1,378 | -0.2% | +11.8% | +15.6% | +10.6% | -2.6% | 41.1 | 1,15,011 |
| 8 | Cipla LimitedCIPLA | Healthcare | 1,395 | +0.2% | +5.2% | -2.6% | -9.0% | -9.4% | 38.9 | 1,12,656 |
| 9 | Mankind Pharma LimitedMANKIND | Healthcare | 2,627 | -0.5% | +15.4% | +10.3% | +15.9% | -2.9% | 48.2 | 1,08,490 |
| 10 | Aurobindo Pharma LimitedAUROPHARMA | Healthcare | 1,794 | -1.6% | +7.6% | +10.3% | +46.8% | -3.5% | 25.9 | 1,03,223 |
| 11 | Max Healthcare Institute LimitedMAXHEALTH | Healthcare | 1,010 | +6.6% | +19.4% | +0.6% | -8.5% | -14.8% | 71.2 | 98,295 |
| 12 | Lupin LimitedLUPIN | Healthcare | 1,977 | -0.2% | +0.8% | -12.5% | -3.8% | -21.9% | 17.4 | 90,388 |
| 13 | Glenmark Pharmaceuticals LimitedGLENMARK | Healthcare | 2,633 | -0.3% | +18.2% | +13.1% | +38.9% | -3.0% | 64.6 | 74,307 |
| 14 | Alkem Laboratories LimitedALKEM | Healthcare | 5,136 | +0.4% | +1.7% | -4.4% | -10.3% | -13.4% | 29.7 | 61,409 |
| 15 | Fortis Healthcare LimitedFORTIS | Healthcare | 803.20 | +5.1% | +9.1% | -11.6% | -14.3% | -20.5% | 58.4 | 60,638 |
| 16 | Biocon LimitedBIOCON | Healthcare | 362.20 | -0.5% | +3.7% | -12.1% | -11.9% | -19.0% | 130.6 | 59,028 |
| 17 | Gland Pharma LimitedGLAND | Healthcare | 3,386 | +1.6% | +11.3% | +16.4% | +85.0% | -1.3% | 45.2 | 55,871 |
| 18 | Abbott India LimitedABBOTINDIA | Healthcare | 25,980 | -1.7% | -0.7% | -3.4% | -11.5% | -15.3% | — | 55,206 |
| 19 | IPCA Laboratories LimitedIPCALAB | Healthcare | 1,866 | -1.0% | +1.8% | -1.0% | +26.1% | -8.5% | 33.7 | 47,329 |
| 20 | Krishna Institute of Medical Sciences LimitedKIMS | Healthcare | 763.35 | +4.6% | +11.3% | -4.6% | +14.8% | -11.0% | 150.9 | 32,061 |

